Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism
The progression of human tuberculosis (TB) to active disease and transmission involves the development of a caseous granuloma that cavitates and releases infectious Mycobacterium tuberculosis bacilli. In the current study, we exploited genome‐wide microarray analysis to determine that genes for lipi...
Gespeichert in:
Veröffentlicht in: | EMBO molecular medicine 2010-07, Vol.2 (7), p.258-274 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The progression of human tuberculosis (TB) to active disease and transmission involves the development of a caseous granuloma that cavitates and releases infectious
Mycobacterium tuberculosis
bacilli. In the current study, we exploited genome‐wide microarray analysis to determine that genes for lipid sequestration and metabolism were highly expressed in caseous TB granulomas. Immunohistological analysis of these granulomas confirmed the disproportionate abundance of the proteins involved in lipid metabolism in cells surrounding the caseum; namely, adipophilin, acyl‐CoA synthetase long‐chain family member 1 and saposin C. Biochemical analysis of the lipid species within the caseum identified cholesterol, cholesteryl esters, triacylglycerols and lactosylceramide, which implicated low‐density lipoprotein‐derived lipids as the most likely source.
M. tuberculosis
infection
in vitro
induced lipid droplet formation in murine and human macrophages. Furthermore, the
M. tuberculosis
cell wall lipid, trehalose dimycolate, induced a strong granulomatous response in mice, which was accompanied by foam cell formation. These results provide molecular and biochemical evidence that the development of the human TB granuloma to caseation correlates with pathogen‐mediated dysregulation of host lipid metabolism. |
---|---|
ISSN: | 1757-4676 1757-4684 |
DOI: | 10.1002/emmm.201000079 |